NeuBase Therapeutics, Inc.NBSE

Market cap

$1.41M

P/E ratio

	2011/09	2012/09	2013/09	2014/09	2015/09	2016/09	2017/09	2018/09	2019/09	2020/09	2021/09	2022/09
Cash and cash equivalents	-	-	-	-	-	13	-	4	10	32	53	23
Total cash & short-term investments	-	-	-	-	-	13	-	4	10	32	53	23
Total current assets	691,755	3	5	13	29	13	13	4	11	33	55	25
Property, plant and equipment, net	19,164	43,111	29,755	104,425	248,753	198,631	63,757	15,763	430,995	1	2	2
Marketable securities, non-current	-	-	-	-	-	-	-	-	586,418	323,557	415,744	-
Total non-current assets	721,091	666,765	575,620	19	17	16	15	8	2	2	9	8
Total assets	1	4	6	32	46	29	28	12	13	34	64	33
Accounts payable	-	-	-	-	-	-	-	-	1	2	2	2
Total current liabilities	6	1	479,737	5	4	4	5	724,998	3	-	4	4
Total non-current liabilities	-	-	-	-	-	-	150,000	-	-	-	6	5
Total liabilities	6	1	479,737	5	4	4	5	724,998	3	3	10	10
Common stock and paid-in capital	22	31	39	70	101	109	131	56	36	75	123	126
Retained earnings	-21,628,748	-21,628,748	-21,628,748	-43,313,548	-58,511,413	-84,277,611	-108,088,607	-121,325,507	-27,000,199	-43,558,602	-68,967,903	-102,744,353
Stockholders' equity	-4,781,753	2	5	27	42	25	23	11	10	31	54	23